Article info
PDFExtended essay
Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Correspondence to Dr Nancy S Jecker, Department of Bioethics & Humanities, University of Washington, Seattle, WA 91895, USA; nsjecker{at}uw.edu
Citation
Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
Publication history
- Received October 31, 2020
- Revised January 17, 2021
- Accepted January 19, 2021
- First published February 16, 2021.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- DEVELOPMENT AND TRANSLATION OF MEDICAL TECHNOLOGIES TO REDUCE HEALTH DISPARITIES (R43 / R44): RFA - EB-12-001
- Research for Health Justice: an ethical framework linking global health research to health equity
- WHO ’s allocation framework for COVAX: is it fair
- Genomic Centers for Infectious Diseases (U19): RFA - AI-13-009
- Priority vaccination for mental illness, developmental or intellectual disability
- NIMHD SOCIAL, BEHAVIORAL, HEALTH SERVICES, AND POLICY RESEARCH ON MINORITY HEALTH AND HEALTH DISPARITIES (R01): RFA - MD-12-003
- Avoiding exploitation in multinational covid-19 vaccine trials
- Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism
- Current tools available for investigating vaccine hesitancy: a scoping review protocol
- Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective